BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8606493)

  • 1. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
    Cho JH; Noguchi M; Ochiai A; Hirohashi S
    Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.
    Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ
    Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
    Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
    J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.
    Greenwald BD; Harpaz N; Yin J; Huang Y; Tong Y; Brown VL; McDaniel T; Newkirk C; Resau JH; Meltzer SJ
    Cancer Res; 1992 Feb; 52(3):741-5. PubMed ID: 1346256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas.
    Medeiros AC; Nagai MA; Neto MM; Brentani RR
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):331-3. PubMed ID: 8061582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
    Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
    Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
    J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
    Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
    Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of tumor suppressor genes in testis cancer.
    Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
    Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotype analysis of esophageal squamous cell carcinoma.
    Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
    Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
    Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
    Brewster SF; Browne S; Brown KW
    J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
    Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.
    Tamura G; Ogasawara S; Nishizuka S; Sakata K; Maesawa C; Suzuki Y; Terashima M; Saito K; Satodate R
    Cancer Res; 1996 Feb; 56(3):612-5. PubMed ID: 8564980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer.
    Wieland I; Böhm M
    Cancer Res; 1994 Apr; 54(7):1772-4. PubMed ID: 7907943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic deletion mapping on chromosome 5 in human carcinomas.
    Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
    Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The multiple tumor suppressor genes in human esophageal cancer].
    Li HC; Lu SX
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):489-91, 519. PubMed ID: 7994660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.